Shriya Goyal retweetledi
If you are a beginner researcher, this paper will help you.
English
Shriya Goyal
93 posts
Shriya Goyal retweetledi
Why don't elephants get cancer?
Our latest episode is up on YouTube. Give it a look and prescribe for future episodes.
youtube.com/watch?v=HbPpfD…
YouTube
English
Shriya Goyal retweetledi
🩸Need a refresher on all things iron deficiency?
Join one of our favorite hematologists, @acweyand, as she helps explain the nuances of iron deficiency!
youtube.com/playlist?list=…
English
Shriya Goyal retweetledi
MSK researchers are applying findings from single-cell technology and computational tools toward understanding and treating metastasis. At #AACR24, @dana_peer discussed results from three studies on how cellular plasticity drives cancer metastasis. More: bit.ly/3VOJeaz
English
Shriya Goyal retweetledi
Don't Miss this important webinar that features the latest research presented at the annual ASH meeting for MDS and AML - Myelodysplastic Syndromes and Acute Myeloid Leukemia.
April 11 at 10:00 AM Eastern Time(US)!
#MDS #acuteleukemia #myelodysplasia #ASH23
English
Shriya Goyal retweetledi
Must listen!! Cancer and cardiovascular disease have so much in common, yet often, the cognitive distraction fails to acknowledge their interconnectedness!
Richard M. Wardrop III, MD, PhD, MACP, SFHM, FAAP@Mud_Fud
Ep10 of the @CCF_IMCHIEFS #IMRP #MedicineGrandRounders is out! Featuring 🌎 expert @DrRohitMoudgil and resident 🤩 @zohamajeed. Listen and subscribe today! @Chatterjee_MD @CleClinicHVTI @CleClinicGME @AndreiBrateanu @NituKataria @OhioAcp @OhioACC @ACPIMPhysicians @ACCinTouch podcasts.apple.com/us/podcast/the…
Cleveland, OH 🇺🇸 English
Shriya Goyal retweetledi
Paging all incoming interns #MedTwitter!
Join us for our intern bootcamp tomorrow, April 2 at 1:30pm EST to learn to differentiate STEMI, NSTEMI, and other myocardial injuries!
You won't want to miss this ~vital~ review. Join for free here! bit.ly/31LWIKg
English
Shriya Goyal retweetledi
Most viewed in the last 7 days from @JAMAOnc:
Do patients with resectable NSCLC and tumor programmed cell death 1 ligand 1 levels less than 1% benefit from neoadjuvant chemoimmunotherapy?
ja.ma/3TELLl3
English
Late-ish news but I’m elated to share that @IowaMed MS3 Srija Manchkanti will be presenting our work on cholangiocarcinoma in primary sclerosing cholangitis at #ASCO24 @UIowaCancer @curecc. So proud to be her peer mentor! 🏆
English
Shriya Goyal retweetledi
Congratulations to this incredible group of interns! We're so excited to have you join our program! #IMmatch #match2024
English
Shriya Goyal retweetledi
Excited and eagerly looking forward to this opportunity!
@ShriyaGoyal5 @LSUHS_IM
The Clinical Problem Solvers@CPSolvers
#MedTwitter We're excited for our morning report with the LSU Health Shreveport Internal Medicine residency program tomorrow, March 9 at 12pm EST! Join us for a fun case and to learn more about their residency program! bit.ly/31LWIKg
English
Shriya Goyal retweetledi
#MedTwitter We're excited for our morning report with the LSU Health Shreveport Internal Medicine residency program tomorrow, March 9 at 12pm EST!
Join us for a fun case and to learn more about their residency program! bit.ly/31LWIKg
English
Shriya Goyal retweetledi
Shriya Goyal retweetledi
The use of the VEGF inhibitors sorafenib, sunitinib, and pazopanib was associated a 2-fold increase in the risk of aortic aneurysm and aortic dissection in patients with cancer. ja.ma/3Il3Ijt
English
Shriya Goyal retweetledi
For patients with polycythemia vera, the hepcidin mimetic rusfertide, which restricts the availability of iron, might be effective for controlling erythrocytosis. Research findings are summarized in a new Quick Take video. nej.md/3SJWjPy
English
Shriya Goyal retweetledi
Measles cases are spreading again in the US. Here's what to know. #MedicalNews
ja.ma/4bS9mXQ
English
Shriya Goyal retweetledi
@ASCO NSCLC Guideline updates👇
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline, Version 2023.3
ascopubs.org/doi/10.1200/JC…
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline, Version 2023.3
ascopubs.org/doi/10.1200/JC…
English
Shriya Goyal retweetledi
This is the #ProstateCancer algorithm we have used during our discussion with @DrRanaMcKay
#MedEd #OncEd #OncTwitter #MedTwitter #gusm @CancerNetwrk
Oncology Brothers@OncBrothers
#ProstateCancer algorithm, w/ @DrRanaMcKay to reiterate the current SoC for this disease: Full Discussion: - cancernetwork.com/treatment-algo… - Oncbrothers.com/algo-prostate-… - Also on the “Oncology Brothers” podcast #OncEd #OncTwitter #MedEd #gusm @CancerNetwrk #MedTwitter
English
Shriya Goyal retweetledi
Excited to see this published in @NEJM. Phase 2 results of REVIVE - studying the efficacy of the hepcidin mimetic, rusfertide in phlebotomy dependent patients with PV. #MPNSM. Phase 3 VERIFY study is ongoing. @doctorpemm @AaronGerds @JeannePalmerMD @AYACOUB7 @MoffittNews
English
English
#ASH2023 @ASH_hematology
Thrilled to be at ASH annual meeting 2023! Grateful for the opportunity to share my research through 1 oral presentation and 2 abstracts, both honored with abstract achievement awards. Huge thanks to my mentor @MukherzSudipto and all the collaborators!
San Diego, CA 🇺🇸 English